Treatments for non–small cell lung cancer

Dernière révision médicale :

If you have non–small cell lung cancer, your healthcare team will create a treatment plan just for you. It will be based on your health and specific information about the cancer. When deciding which treatments to offer for non–small cell lung cancer, your healthcare team will consider:

  • the stage of the cancer
  • whether the cancer can be removed with surgery
  • any genetic changes to the lung cancer cells
  • immune checkpoint markers in lung cancer cells
  • your overall health, including your lung function
  • your personal preferences (what you want)

Révision par les experts et références

  • Stephen Lam, MD, FRCPC
  • American Cancer Society. Treating Non–Small Cell Lung Cancer. 2019: https://www.cancer.org/cancer/lung-cancer/treating-non-small-cell.html.
  • Cancer Care Ontario. Non-small Cell Lung Cancer Treatment Pathway Map. 2019: Version 2019.05.
  • National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer (Version 3.2020). 2020:
  • Brahmer JR, Covindan R, Anders RA, Antonia SJ, Sagorksy S, et al. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC). Journal for ImmunoTherapy of Cancer. 2018: 6:75.
  • Dong J, Li B, Lin D, Zhou Q, Huang D. Advances in targeted therapy and immunotherapy for non–small cell lung cancer based on accurate molecular typing. Frontiers in Pharmacology. 2019: 10:230.
  • Osmani L, Askin F, Gabrielson E, Li QK. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): moving from targeted therapy to immunotherapy. Seminars in Cancer Biology. 52(Pt 1): 103-109. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970946/.
  • Sui H, Ningxia M, Wang Y, Li H, Xiaoming L, Su Y, Yang J. Anti-PD1/PD-L1 therapy for non-small cell lung cancer: toward personalized medicine and combination strategies. Journal of Immunology Research. 2018: 2018: 6984948. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109480/.
  • Lee SH. Chemotherapy for lung cancer in the era of personalized medicine. Tuberculosis and Respiratory Diseases. 2019: 82:179–189.
  • PDQ® Adult Treatment Editorial Board. Non–Small Cell Lung Cancer Treatment (PDQ®) – Health Professional Version. Bethesda, MD: National Cancer Institute; 2020: https://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq.
  • Kendall F, Abreu P, Pinho P, Olivera J, Bastos P. The role of physiotherapy in patients undergoing pulmonary surgery for lung cancer. a literature review. Revista Portugesa de Pneumolgia. 2017: November-December:343-351. https://www.sciencedirect.com/science/article/pii/S2173511517300751?via%3Dihub.

Treatments for stage 0 non–small cell lung cancer

The following are treatment options for stage 0 non−small cell lung cancer. The types of treatments given are based on the unique needs of the person with cancer.

Treatments for stage 1 non–small cell lung cancer

The following are treatment options for stage 1 non–small cell lung cancer. The types of treatments given are based on the unique needs of the person with cancer.

Treatments for stage 2 non–small cell lung cancer

The following are treatment options for stage 2 non–small cell lung cancer. The types of treatments given are based on the unique needs of the person with cancer.

Treatments for stage 3 non–small cell lung cancer

The following are treatment options for stage 3 non–small cell lung cancer. The types of treatments given are based on the unique needs of the person with cancer.

Treatments for stage 4 non–small cell lung cancer

The following are treatment options for stage 4 non–small cell lung cancer. Stage 4 non–small cell lung cancer is very difficult to treat because it has spread to distant sites throughout the body. The types of treatments given are based on the unique needs of the person with cancer.

Treatments for recurrent non–small cell lung cancer

The following are treatment options for recurrent non−small cell lung cancer. The types of treatment offered for recurrent non−small cell lung cancer depend on the unique needs of the person with cancer.

Treatments for small cell lung cancer

If you have small cell lung cancer, your healthcare team will create a treatment plan just for you. It will be based on your health and specific information about the cancer.

Surgery for lung cancer

Surgery may be used to treat non–small cell lung cancer (NSCLC). It is used to potentially cure the cancer by completely removing the tumour. Surgery is rarely offered if the tumour cannot be completely removed.

Chemotherapy for lung cancer

Chemotherapy is commonly used to treat lung cancer.

Radiation therapy for lung cancer

Radiation therapy uses high-energy rays or particles to destroy cancer cells.

Targeted therapy for non–small cell lung cancer

Some people with non–small cell lung cancer have targeted therapy. It uses drugs to target specific molecules (such as proteins) on cancer cells or inside them.

Immunotherapy for non–small cell lung cancer

Some people with non–small cell lung cancer may have immunotherapy. Immunotherapy uses natural or artificial substances that change the way cells behave.

Endobronchial therapies for lung cancer

Endobronchial therapies are treatments given during bronchoscopy. For endobronchial therapies to be effective, the bronchoscope must reach the tumour.

Follow-up after treatment for lung cancer

Lung cancer behaves differently in each person, and a standard follow-up schedule would not work for everyone. People with lung cancer should talk to their doctor about a follow-up plan that suits their individual situation.

Votre source de confiance pour des informations fiables sur le cancer

Le soutien des lecteurs comme vous nous permet de continuer à fournir des informations de la plus haute qualité sur plus de 100 types de cancer.

Nous sommes là pour vous garantir un accès facile à des informations fiables sur le cancer, ainsi qu’aux millions de personnes qui visitent ce site Web chaque année. Mais nous ne pouvons pas y arriver seuls.

Chaque don nous permet d’offrir des informations fiables sur le cancer et finance des services de soutien empreints de compassion et des projets de recherche prometteurs. Faites un don dès maintenant, car chaque dollar compte. Nous vous remercions.

Non-responsabilité médicale

L'information fournie par la Société canadienne du cancer ne saurait remplacer le lien qui vous unit à votre médecin. Nos renseignements sont d’ordre général; avant de prendre toute décision de nature médicale ou si vous avez des questions concernant votre état de santé personnel, assurez-vous de parler à un professionnel de la santé qualifié.

Nous faisons le maximum pour que les renseignements que nous diffusons soient toujours exacts et fiables, mais nous ne pouvons garantir leur exhaustivité, pas plus que l’absence totale d’erreur.

La Société canadienne du cancer n’assume aucune responsabilité quant à la qualité des renseignements ou des services offerts par d'autres organismes mentionnés sur cancer.ca, pas plus qu’elle ne cautionne un service, un produit, un traitement ou une thérapie en particulier. 


1-888-939-3333 | cancer.ca | © 2026 Canadian Cancer Society